IMMIX BIOPHARMA INC (IMMX)
US45258H1068 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -15.60M | -8.23M | -24.38M | -1.15M | -970.00K | |||
| Depreciation Amortization | 5.47K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Change In Working Capital | 1.65M | 200.00K | -390.00K | 170.00K | 180.00K | |||
| Interest Paid | 0.00 | 10.00K | 0.00 | 0.00 | 0.00 | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 20.00K | 20.00K | |||
| Other non cash items | 2.57M | 620.00K | 23.18M | 580.00K | 0.00 | |||
| OPERATING CASH FLOW | -11.37M | -7.41M | -1.59M | -400.00K | -790.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -52.09K | 0.00 | 0.00 | 0.00 | -10.00K | |||
| INVESTING CASH FLOW | -52.09K | 0.00 | 0.00 | 0.00 | -10.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -50.00K | 200.00K | 0.00 | 1.05M | |||
| Stock Issued/Repurchased | 15.70M | 2.81M | 18.65M | N/A | N/A | |||
| Other Financing Activity | -234.62K | 470.00K | N/A | 0.00 | N/A | |||
| FINANCING CASH FLOW | 15.46M | 3.23M | 18.85M | 0.00 | 1.05M | |||
| Exchange Rate Effect | 33.09K | -30.00K | -10.00K | 60.00K | 20.00K | |||
| CHANGE IN CASH | 4.07M | -4.21M | 17.25M | -340.00K | 270.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -11.37M | -7.41M | -1.59M | -400.00K | -790.00K | |||
| Capital Expenditure | -52.09K | 0.00 | 0.00 | 0.00 | -10.00K | |||
| FREE CASH FLOW | -11.42M | -7.41M | -1.59M | -400.00K | -800.00K | |||
All data in USD